tiprankstipranks
Trending News
More News >
Biogen Inc. (BIIB)
:BIIB
US Market
Advertisement

Biogen (BIIB) Ratios

Compare
4,895 Followers

Biogen Ratios

BIIB's free cash flow for Q2 2025 was $0.77. For the 2025 fiscal year, BIIB's free cash flow was decreased by $ and operating cash flow was $0.31. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.50 2.00 2.99 1.83 1.84
Quick Ratio
1.79 1.26 2.58 1.51 1.55
Cash Ratio
0.87 0.31 1.04 0.53 0.36
Solvency Ratio
0.21 0.14 0.32 0.16 0.32
Operating Cash Flow Ratio
0.66 0.45 0.42 0.85 1.13
Short-Term Operating Cash Flow Coverage
0.00 10.31 0.00 3.64 0.00
Net Current Asset Value
$ -2.73B$ -5.19B$ -1.37B$ -5.06B$ -7.05B
Leverage Ratios
Debt-to-Assets Ratio
0.23 0.27 0.27 0.32 0.32
Debt-to-Equity Ratio
0.37 0.50 0.49 0.69 0.73
Debt-to-Capital Ratio
0.27 0.33 0.33 0.41 0.42
Long-Term Debt-to-Capital Ratio
0.26 0.31 0.32 0.36 0.41
Financial Leverage Ratio
1.61 1.81 1.83 2.18 2.30
Debt Service Coverage Ratio
10.01 5.65 15.10 1.94 21.29
Interest Coverage Ratio
9.60 8.49 9.41 11.20 20.45
Debt to Market Cap
0.31 0.19 0.16 0.20 0.19
Interest Debt Per Share
46.93 52.42 47.22 52.70 50.04
Net Debt to EBITDA
1.37 2.65 0.73 2.15 1.13
Profitability Margins
Gross Profit Margin
75.43%74.24%77.61%80.79%86.57%
EBIT Margin
20.51%19.14%37.73%18.20%39.20%
EBITDA Margin
27.95%24.17%42.83%22.64%42.62%
Operating Profit Margin
24.25%21.32%22.81%25.87%33.84%
Pretax Profit Margin
17.98%13.18%35.31%15.89%37.54%
Net Profit Margin
15.31%11.81%29.95%14.17%29.76%
Continuous Operations Profit Margin
15.31%11.81%29.11%15.73%30.20%
Net Income Per EBT
85.14%89.54%84.83%89.16%79.26%
EBT Per EBIT
74.16%61.83%154.81%61.44%110.93%
Return on Assets (ROA)
5.40%4.33%12.41%6.52%16.25%
Return on Equity (ROE)
9.04%7.85%22.76%14.20%37.44%
Return on Capital Employed (ROCE)
9.64%8.96%10.90%14.51%21.80%
Return on Invested Capital (ROIC)
8.21%7.94%8.94%13.33%17.44%
Return on Tangible Assets
12.37%9.47%17.97%9.79%25.36%
Earnings Yield
7.69%3.10%7.57%4.35%10.15%
Efficiency Ratios
Receivables Turnover
4.80 4.68 4.76 5.60 5.78
Payables Turnover
6.01 6.28 4.64 3.58 3.97
Inventory Turnover
1.08 1.00 1.69 1.56 1.69
Fixed Asset Turnover
2.91 2.64 2.75 2.90 3.50
Asset Turnover
0.35 0.37 0.41 0.46 0.55
Working Capital Turnover Ratio
2.81 1.98 2.02 3.28 4.04
Cash Conversion Cycle
353.33 383.96 213.29 197.09 187.27
Days of Sales Outstanding
76.09 77.93 76.65 65.20 63.18
Days of Inventory Outstanding
337.93 364.14 215.38 233.82 216.06
Days of Payables Outstanding
60.68 58.11 78.74 101.94 91.98
Operating Cycle
414.02 442.07 292.03 299.02 279.25
Cash Flow Ratios
Operating Cash Flow Per Share
14.51 10.69 9.53 24.41 26.29
Free Cash Flow Per Share
12.73 8.54 7.85 22.43 22.86
CapEx Per Share
1.78 2.15 1.67 1.98 3.43
Free Cash Flow to Operating Cash Flow
0.88 0.80 0.82 0.92 0.87
Dividend Paid and CapEx Coverage Ratio
8.14 4.97 5.69 12.34 7.67
Capital Expenditure Coverage Ratio
8.14 4.97 5.69 12.34 7.67
Operating Cash Flow Coverage Ratio
0.32 0.21 0.21 0.48 0.54
Operating Cash Flow to Sales Ratio
0.21 0.16 0.14 0.33 0.31
Free Cash Flow Yield
9.29%3.30%2.84%9.35%9.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
13.00 32.25 13.21 22.99 9.85
Price-to-Sales (P/S) Ratio
2.00 3.81 3.96 3.26 2.93
Price-to-Book (P/B) Ratio
1.13 2.53 3.01 3.26 3.69
Price-to-Free Cash Flow (P/FCF) Ratio
10.77 30.30 35.26 10.69 10.71
Price-to-Operating Cash Flow Ratio
9.40 24.20 29.07 9.83 9.31
Price-to-Earnings Growth (PEG) Ratio
3.88 -0.52 0.13 -0.40 -0.47
Price-to-Fair Value
1.13 2.53 3.01 3.26 3.69
Enterprise Value Multiple
8.53 18.40 9.97 16.54 8.01
Enterprise Value
23.83B 43.73B 43.43B 41.11B 45.89B
EV to EBITDA
8.53 18.40 9.97 16.54 8.01
EV to Sales
2.38 4.45 4.27 3.74 3.41
EV to Free Cash Flow
12.83 35.39 38.06 12.29 12.48
EV to Operating Cash Flow
11.26 28.27 31.37 11.30 10.85
Tangible Book Value Per Share
11.47 1.50 39.84 19.97 11.43
Shareholders’ Equity Per Share
120.86 102.28 92.14 73.51 66.41
Tax and Other Ratios
Effective Tax Rate
0.15 0.10 0.18 0.03 0.20
Revenue Per Share
68.52 67.97 70.02 73.65 83.56
Net Income Per Share
10.49 8.02 20.97 10.44 24.86
Tax Burden
0.85 0.90 0.85 0.89 0.79
Interest Burden
0.88 0.69 0.94 0.87 0.96
Research & Development to Revenue
0.19 0.25 0.22 0.23 0.30
SG&A to Revenue
0.00 0.25 0.23 0.23 0.18
Stock-Based Compensation to Revenue
0.03 0.03 0.02 0.02 0.01
Income Quality
1.38 1.33 0.47 2.11 1.04
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis